LEUCOSACCHARIDE
LIVE

Serial Number

79238821

Owner

Noster Inc.

Filing Date

May 18, 2018

Add to watchlist:

No watchlists yet
View on USPTO

LEUCOSACCHARIDE Trademark

Serial Number: 79238821 • Registration: 5929117

LEUCOSACCHARIDE is a trademark filed by Noster Inc. on May 18, 2018. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 16 (Paper Goods), Class 29 (Meats & Processed Foods), Class 30 (Staple Foods), Class 32 (Light Beverages), Class 33 (Wine & Spirits), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Noster Inc. (26 trademarks)

35-3, Minamibiraki,

Entity Type: 99

NITTO PHARMACEUTICAL INDUSTRIES, LTD. (14 trademarks)

35-3, Minamibiraki,

Entity Type: 03

Trademark Details

Filing Date

May 18, 2018

Registration Date

December 10, 2019

Published for Opposition

September 24, 2019

Cancellation Date

June 26, 2026

Goods & Services

Milk products excluding ice cream, ice milk and frozen yogurt; edible oils and fats; fresh, chilled, or frozen meat for human consumption; fresh, chilled or frozen edible aquatic animals, not live; processed meat products, namely, dried meat and chicken, meat, or fish croquettes, sausages, ham and bacon; processed seafood products other than blocks of boiled, smoked and then dried bonitos, dried pieces of agar jelly, flakes of dried fish meat, fishmeal for human consumption, edible shavings of dried kelp, sheets of dried laver, dried brown alga, dried edible seaweed and toasted sheets of laver, namely, tinned and processed fish; processed vegetables and fruits; protein for use as a food additive, namely, textured vegetable protein for use as a meat extender

Pharmaceutical preparations other than for agricultural purposes for the treatment and prevention of metabolic and endocrine diseases, namely, diabetes, diabetic complication, hyperlipidemia, hyperuricemia, gout, lifestyle related disease, nutritional disorders, impaired glucose tolerance, metabolic syndrome, obesity and lipid disorder, cardiovascular, urological and reproductive diseases, namely, hypertension, hyperglycemia, ischemic heart disease, hyperinsulinemia, arteriosclerosis, myocardial infarction, angina pectoris, aneurysm, chronic kidney disease, renal calculi, kidney disease, pyelonephritis, nephritis, urethritis, cystitis, hypercholesterolemia and high triglyceridemia, respiratory diseases, namely, bronchitis, pulmonary emphysema and lung inflammation, digestive and oral diseases, namely, abnormality of the intestinal flora, abdominal distension, peptic ulcer, intestinal disease, inflammatory disorder, irritable bowel syndrome, gastric ulcer, inflammatory bowel disease, Crohn's disease, diverticulitis, liver cirrhosis, fatty liver, diarrhea, constipation, loose stool disease, hepatic inflammation, non-alcoholic steatohepatitis, viral hepatitis, alcoholic hepatitis, dental disease, periodontal diseases, stomatitis, xerostomia and cyst, immune, inflammatory and allergic diseases, namely, immune related diseases and abnormalities, type I, II, III, IV and V allergy, pollinosis, atopic dermatitis, psoriasis, autoimmune disease and connective tissue disease, bone and articular diseases, namely, rheumatism, osteoporosis and articular inflammation, pathogenic microbial and malignant neoplastic diseases, namely, infection, cancer and malignant tumor, mental and nervous system diseases, namely, mental disorder, dementia, Alzheimer's disease, bipolar disorder, depression, anorexia, insomnia, cerebral apoplexy, cerebral infarction, autism, neuroinflammation, overwork related disease and nerve inflammation related diseases and cancers resulting from chronic inflammation, and sensory system and skin diseases, namely, ophthalmic disease, ocular inflammation, otorhinolaryngology disease and skin inflammation; pharmaceutical preparations in the nature of medicines for dental purposes; reagent paper for medical purposes; oiled paper for medical purposes; drug delivery agents in the form of edible wrapping wafers for medicine doses; gauze for dressings; empty capsules for pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; antiseptic liquid bandages; breast-nursing pads; cotton swabs for medical use; dental materials, namely, dental adhesives; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic food adapted for medical purposes; beverages for babies, namely, infant formula; food for babies; dietary supplements for animals

Lactic acid bacteria powder for producing food, dietary supplements for humans or beverages; other microorganism, namely, bacteria and bacteria powder for producing food, dietary supplements for humans or beverages; polysaccharides for producing food, dietary supplements for humans or beverages; chemical products for the fresh-keeping and preserving of food; glue and adhesives for industrial purposes; plant growth regulating preparations; fertilizers; higher fatty acids for industrial purposes; unprocessed plastics; gluten for the food industry

Advertising and publicity services

Whey beverages; carbonated non-alcoholic drinks being refreshing beverages; fruit juices; vegetable juices being beverages; beer; extracts of hops for making beer

Awamori being distilled rice spirits; sake substitute, namely, yellow rice wine; Japanese white liquor being shochu; Japanese sweet rice-based mixed liquor being shiro-zake; Sake; Japanese regenerated liquors being naoshi; Japanese shochu-based mixed liquor being mirin; western liquors in general; alcoholic fruit beverages; Japanese shochu-based mixed liquor beverages being chuhai; Chinese liquors in general; flavored liquors

Tea; coffee roasted, powdered, granulated, or in drinks; cocoa roasted, powdered, granulated, or in drinks; confectionery made of sugar, sugar substitutes derived from microorganism, or sugar substitutes derived from polysaccharide; bread and buns; sandwiches; steamed buns stuffed with minced meat; hamburgers being sandwiches; pizzas; hot dogs being sandwiches; meat pies; cube sugar; fructose for culinary purposes; crystal sugar not being confectionery; sugar; maltose for culinary purposes; honey; glucose for culinary purposes; powdered starch syrup for culinary purposes; starch syrup for culinary purposes; ice cream mixes; sherbet mixes; flour

Cosmetics; cosmetic soaps and detergents for household use; dentifrices; perfume and flavour materials, namely, food flavorings prepared from essential oils or polysaccharide sold as an integral component of essential oils derived from microorganisms; false nails; false eyelashes; breath freshening preparations for personal hygiene; deodorants for animals; incense

Paper and cardboard; printed matter, namely, paper signs, books, manuals, curricula, newsletters, informational cards and brochures in the field of health

Filing History

CANCELLED SECTION 71
Jun 26, 2026 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Dec 10, 2024 REM3
CHANGE OF OWNER RECEIVED FROM IB
Feb 12, 2021 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 17, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 26, 2020 FICS
FINAL DISPOSITION PROCESSED
Mar 26, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 10, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 10, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 24, 2019 NPUB
PUBLISHED FOR OPPOSITION
Sep 24, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Sep 20, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 4, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 4, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 4, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 22, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 21, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 20, 2019 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 20, 2019 ERFR
NOTICE OF REINSTATEMENT E-MAILED
Aug 16, 2019 MREI
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Aug 15, 2019 GNS1
CONTINUATION OF FINAL REFUSAL E-MAILED
Aug 15, 2019 GNCF
ACTION CONTINUING A FINAL - COMPLETED
Aug 15, 2019 CNCF
REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED
Aug 12, 2019 RGIA
ABANDONMENT NOTICE MAILED - INCOMPLETE RESPONSE
Aug 12, 2019 MAB0
ABANDONMENT - INCOMPLETE RESPONSE
Aug 12, 2019 ABN0
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 19, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 19, 2019 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 17, 2019 ERFR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 5, 2019 TCCA
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 18, 2019 GNFN
FINAL REFUSAL E-MAILED
Jan 18, 2019 GNFR
FINAL REFUSAL WRITTEN
Jan 18, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 7, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 7, 2018 CRFA
ASSIGNED TO LIE
Nov 5, 2018 ALIE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 25, 2018 TCCA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 25, 2018 TROA
REFUSAL PROCESSED BY IB
Oct 7, 2018 RFNT
ATTORNEY REVIEW COMPLETED
Oct 4, 2018 ATRV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Oct 4, 2018 CREV
CORRECTION TRANSACTION RECEIVED FROM IB
Sep 28, 2018 CRCV
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 19, 2018 RFCS
REFUSAL PROCESSED BY MPU
Sep 19, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 14, 2018 RFCR
NON-FINAL ACTION WRITTEN
Sep 13, 2018 CNRT
ASSIGNED TO EXAMINER
Sep 10, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 25, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 21, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 16, 2018 REPR